Chugai Pharmaceutic-Unsp ADRCHGCY
13F holders, Q2 2024 (June 30)6holders −3
0new positions
3sold out
$17.77avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, down 3 from Q1 2024. 0 opened new positions and 3 sold out. The largest holders were Todd Asset Management LLC ($4.1M), Confluence Investment Management LLC ($703K) and Rhumbline Advisers ($556K).
- Company
- Chugai Pharmaceutic-Unsp ADR
- CUSIP
- 171269103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $270K |
All 13F filers, Q1 2024 → Q2 2024: 48,338 shares bought and 17,707 shares sold, net +30,631 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Todd Asset Management LLC | 0.09% | Add +23.1% | 231,086 | $4.1M |
| Confluence Investment Management LLC | 0.01% | Add +2.2% | 39,586 | $703K |
| Rhumbline Advisers | 0.00% | Add +15.3% | 31,287 | $556K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -15.5% | 16,260 | $289K |
| GAMMA Investing LLC | 0.01% | Reduce -9.4% | 5,738 | $102K |
| Richardson Financial Services Inc. | 0.00% | No change | 14 | $249 |
"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.